TAB3 Antibody - #DF2369
| 製品: | TAB3 Antibody |
| カタログ: | DF2369 |
| タンパク質の説明: | Rabbit polyclonal antibody to TAB3 |
| アプリケーション: | WB IF/ICC |
| 反応性: | Human, Mouse |
| 予測: | Pig, Horse, Sheep, Rabbit, Dog, Chicken |
| 分子量: | 79 kDa; 79kD(Calculated). |
| ユニプロット: | Q8N5C8 |
| RRID: | AB_2839577 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF2369, RRID:AB_2839577.
折りたたみ／展開
MAP3K7IP 3; Mitogen-activated protein kinase kinase kinase 7-interacting protein 3; NAP1; NF-kappa-B-activating protein 1; NFkB activating protein 1; TAB-3; Tab3; TAB3_HUMAN; TAK1 binding protein 3; TAK1-binding protein 3; TGF-beta-activated kinase 1 and MAP3K7-binding protein 3; TGF-beta-activated kinase 1-binding protein 3;
免疫原
Widely expressed. Constitutively overexpressed in certain tumor tissues. Isoform 1 is a major transcript while isoform 2 is a minor transcript.
- Q8N5C8 TAB3_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAQSSPQLDIQVLHDLRQRFPEIPEGVVSQCMLQNNNNLEACCRALSQESSKYLYMEYHSPDDNRMNRNRLLHINLGIHSPSSYHPGDGAQLNGGRTLVHSSSDGHIDPQHAAGKQLICLVQEPHSAPAVVAATPNYNPFFMNEQNRSAATPPSQPPQQPSSMQTGMNPSAMQGPSPPPPPPSYMHIPRYSTNPITVTVSQNLPSGQTVPRALQILPQIPSNLYGSPGSIYIRQTSQSSSGRQTPQSTPWQSSPQGPVPHYSQRPLPVYPHQQNYQPSQYSPKQQQIPQSAYHSPPPSQCPSPFSSPQHQVQPSQLGHIFMPPSPSTTPPHPYQQGPPSYQKQGSHSVAYLPYTASSLSKGSMKKIEITVEPSQRPGTAINRSPSPISNQPSPRNQHSLYTATTPPSSSPSRGISSQPKPPFSVNPVYITYTQPTGPSCTPSPSPRVIPNPTTVFKITVGRATTENLLNLVDQEERSAAPEPIQPISVIPGSGGEKGSHKYQRSSSSGSDDYAYTQALLLHQRARMERLAKQLKLEKEELERLKSEVNGMEHDLMQRRLRRVSCTTAIPTPEEMTRLRSMNRQLQINVDCTLKEVDLLQSRGNFDPKAMNNFYDNIEPGPVVPPKPSKKDSSDPCTIERKARRISVTSKVQADIHDTQAAAADEHRTGSTQSPRTQPRDEDYEGAPWNCDSCTFLNHPALNRCEQCEMPRYT
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q8N5C8 基板として
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| A2 | Acetylation | Uniprot | |
| S5 | Phosphorylation | Uniprot | |
| Y53 | Phosphorylation | Uniprot | |
| Y55 | Phosphorylation | Uniprot | |
| Y58 | Phosphorylation | Uniprot | |
| S60 | Phosphorylation | Uniprot | |
| S80 | Phosphorylation | Uniprot | |
| S82 | Phosphorylation | Uniprot | |
| S83 | Phosphorylation | Uniprot | |
| Y84 | Phosphorylation | Uniprot | |
| T97 | Phosphorylation | Uniprot | |
| S101 | Phosphorylation | Uniprot | |
| S102 | Phosphorylation | Uniprot | |
| S103 | Phosphorylation | Uniprot | |
| S126 | Phosphorylation | Uniprot | |
| T134 | Phosphorylation | Uniprot | |
| Y224 | Phosphorylation | Uniprot | |
| R264 | Methylation | Uniprot | |
| K283 | Methylation | Uniprot | |
| T354 | Phosphorylation | Uniprot | |
| S385 | Phosphorylation | Uniprot | |
| T404 | Phosphorylation | Uniprot | |
| S407 | Phosphorylation | Uniprot | |
| S408 | O-Glycosylation | Uniprot | |
| S408 | Phosphorylation | Uniprot | |
| S409 | Phosphorylation | Uniprot | |
| Y428 | Phosphorylation | Uniprot | |
| T440 | Phosphorylation | Uniprot | |
| S442 | Phosphorylation | Uniprot | |
| S444 | Phosphorylation | Uniprot | |
| S492 | Phosphorylation | Uniprot | |
| S504 | Phosphorylation | Uniprot | |
| S506 | Phosphorylation | Uniprot | |
| Y512 | Phosphorylation | Uniprot | |
| S563 | Phosphorylation | Uniprot | |
| Y613 | Phosphorylation | Uniprot | |
| S627 | Phosphorylation | Uniprot | |
| S645 | Phosphorylation | Uniprot | |
| T657 | Phosphorylation | Uniprot |
研究背景
Adapter linking MAP3K7/TAK1 and TRAF6 or TRAF2. Mediator of MAP3K7 activation, respectively in the IL1 and TNF signaling pathways. Plays a role in activation of NF-kappa-B and AP1 transcription factor. Isoform 2 may be an oncogenic factor.
Ubiquitinated; following IL1 stimulation or TRAF6 overexpression.
Phosphorylated at Ser-506 by MAPKAPK2 and MAPKAPK3 following IL1 treatment.
Widely expressed. Constitutively overexpressed in certain tumor tissues. Isoform 1 is a major transcript while isoform 2 is a minor transcript.
Interacts with TAB1, TAB2, MAP3K7, TRAF2 and TRAF6. The minimal TAB3-containing complex (TAB1-MAP3K7-TAB3) appears not to contain TAB2. However, it seems sensible to consider that TAB2 may also join this complex and may act in a cooperative manner with TAB3. Interacts with WDR34 (via the WD domains). Interacts with RBCK1. Binds 'Lys-63'-linked polyubiquitin chains. Interacts with TRIM5.
The RanBP2-type zinc finger (NZF) mediates binding to two consecutive 'Lys-63'-linked ubiquitins.
研究領域
· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > TNF signaling pathway. (View pathway)
· Organismal Systems > Immune system > NOD-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > IL-17 signaling pathway. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.